1. Home
  2. RXST vs PSEC Comparison

RXST vs PSEC Comparison

Compare RXST & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • PSEC
  • Stock Information
  • Founded
  • RXST 1997
  • PSEC 2004
  • Country
  • RXST United States
  • PSEC United States
  • Employees
  • RXST N/A
  • PSEC N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PSEC Finance/Investors Services
  • Sector
  • RXST Health Care
  • PSEC Finance
  • Exchange
  • RXST Nasdaq
  • PSEC Nasdaq
  • Market Cap
  • RXST 553.1M
  • PSEC N/A
  • IPO Year
  • RXST 2021
  • PSEC 2004
  • Fundamental
  • Price
  • RXST $8.03
  • PSEC $3.33
  • Analyst Decision
  • RXST Hold
  • PSEC Sell
  • Analyst Count
  • RXST 11
  • PSEC 1
  • Target Price
  • RXST $19.40
  • PSEC $3.00
  • AVG Volume (30 Days)
  • RXST 1.8M
  • PSEC 2.7M
  • Earning Date
  • RXST 08-07-2025
  • PSEC 08-27-2025
  • Dividend Yield
  • RXST N/A
  • PSEC 16.27%
  • EPS Growth
  • RXST N/A
  • PSEC N/A
  • EPS
  • RXST N/A
  • PSEC N/A
  • Revenue
  • RXST $148,310,000.00
  • PSEC $764,750,000.00
  • Revenue This Year
  • RXST $17.41
  • PSEC N/A
  • Revenue Next Year
  • RXST $12.44
  • PSEC N/A
  • P/E Ratio
  • RXST N/A
  • PSEC N/A
  • Revenue Growth
  • RXST 46.70
  • PSEC N/A
  • 52 Week Low
  • RXST $6.32
  • PSEC $3.10
  • 52 Week High
  • RXST $58.23
  • PSEC $5.63
  • Technical
  • Relative Strength Index (RSI)
  • RXST 21.66
  • PSEC 54.24
  • Support Level
  • RXST $6.32
  • PSEC $3.28
  • Resistance Level
  • RXST $8.50
  • PSEC $3.35
  • Average True Range (ATR)
  • RXST 0.77
  • PSEC 0.07
  • MACD
  • RXST -0.52
  • PSEC 0.03
  • Stochastic Oscillator
  • RXST 21.50
  • PSEC 92.00

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: